COMMUNIQUÉS West-GlobeNewswire

FSD Pharma's Investments Provide Unique Diversification -- CFN Media
05/03/2019
SEATTLE, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Otonomy to Participate in Two Upcoming Investor Conferences
05/03/2019
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D [...]
Xbrane Biopharma and Redeye invites to a company presentation in Malmö 7th of March.
05/03/2019
Press release 2019-03-05 Xbrane Biopharma and Redeye invites to a company presentation at Clarion Hotel, Dag Hammarskjölds Torg 2 in Malmö on the 7 th of March, between 18.00-20.00 CEST. Xbrane Biopharma will be [...]
Amarin to Present at Cowen’s 39th Annual Health Care Conference
05/03/2019
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Ninth Annual “Mardi Gras for Autism” Opens $9 Pledge Campaign Helping Nine Students
05/03/2019
FULLERTON, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- To celebrate the ninth year of the FREE family carnival benefit, “Mardi Gras for Autism,” Fullerton Cares launches the $9 pledge helping 9 students campaign on March [...]
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2018 Earnings Release Date and Conference Call Details
05/03/2019
NASHVILLE, Tenn., March 05, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading healthcare services company, today announced that the Company will release its [...]
RadNet, Inc. Announces Date of its Fourth Quarter 2018 Financial Results Conference Call
05/03/2019
LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
The Ensign Group Acquires California Skilled Nursing Facility
05/03/2019
MISSION VIEJO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
CampDoc Launches Discounted Epinephrine Auto-Injector Pricing Program for Camps
05/03/2019
ANN ARBOR, Mich., March 05, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps, announced the launch of CampEpi, a new program offering discounted epinephrine auto-injector pricing [...]
PDMR Dealing
05/03/2019
LONDON, March 05, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Transactions in relation to share buyback program
05/03/2019
Transactions in relation to share buyback program Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the [...]
DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors
05/03/2019
Montrouge, France, March 5, 2019 DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors Mr. de Rosen to succeed DBV’s co-founder, Dr. Pierre-Henri Benhamou, who [...]
DBV Technologies annonce la nomination de Michel de Rosen en tant que Président non-exécutif du conseil d'administration
05/03/2019
Montrouge, France, 5 mars (7 h 30 CET) 2019 DBV Technologies annonce la nomination de Michel de Rosen en tant que Président non-exécutif du conseil d'administration Michel de Rosen succède au co-fondateur de DBV, le Dr [...]
Novartis Cosentyx® shows superior improvements in psoriasis patients' quality of life versus Janssen's IL-23 Stelara®*
05/03/2019
New CLARITY data show over two-thirds of Cosentyx (secukinumab) treated patients with moderate to severe psoriasis reported no impact of skin disease on their quality of life (QoL) up to Week 16 compared to Stelara [...]
MDxHealth : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines
05/03/2019
NEWS RELEASE MDxHealth's SelectMDx ® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines A significant milestone to increase adoption of SelectMDx in Italy IRVINE, CA, and [...]
Darolutamide submitted for marketing authorization in Japan
05/03/2019
Orion Corporation Press release 5 March 2019 at 8.00 a.m. EET Darolutamide submitted for marketing authorization in Japan Regulatory submission based on positive data from the Phase III ARAMIS trial Orion Corporation [...]
ObsEva Reports Fourth Quarter and Full Year 2018 Financial Results, Provides Business Update
05/03/2019
Major 2018 Accomplishments Driven by Positive Clinical Trial Results - Significant increase in rates of pregnancy and live birth (up to 35% increase in Day 5 ET) in Phase 3 IMPLANT 2 trial of nolasiban in IVF procedures [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
05/03/2019
Regulated information Gosselies, Belgium, 5 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
05/03/2019
Information réglementée Gosselies, Belgique, le 5 mars 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]

Pages